Acadian Asset Management LLC Albireo Pharma, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$23.19 - $41.61 $274,731 - $492,953	-11,847 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$14.82 - $29.92 $48,624 - $98,167	-3,281 Reduced 21.69%	11,847 $313,000
Q1 2020 May 11, 2020	BUY	$11.67 - $27.23 $176,543 - $411,935	15,128 New	15,128 $247,000
Q2 2019 Aug 08, 2019	SELL	$30.67 - $37.86 $156,018 - $192,593	-5,087 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$22.22 - $32.21 $51,683 - $74,920	-2,326 Reduced 31.38%	5,087 $164,000

Q4 2018 Feb 07, 2019	SELL	$20.9 - $32.57 $22,990 - $35,827	-1,100 Reduced 12.92%	7,413 $182,000
Q3 2018 Oct 30, 2018	BUY	$29.29 - $36.87 $113,293 - $142,613	3,868 Added 83.27%	8,513 $281,000
Q2 2018 Jul 24, 2018	BUY	$28.9 - $37.31 $134,240 - $173,304	4,645 New	4,645 $165,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.